Vendor, San Carlos, CA
Gencyte Therapeutics Inc.
UEI KLLTVAECBMN8, CAGE 7ZVP4
2 awards and $499,990 obligated between February 26, 2024 and July 16, 2026, 100% under full and open competition, against 16.5 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $499,990 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 2 |
| Small Business Set Aside - Total | 1 |
| Small Business Set Aside - Partial | 1 |
| Definitive Contract | 2 |
Hear when Gencyte Therapeutics Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Gencyte Therapeutics Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $499,990
- Soonest
- May 31, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00046Definitive Contract, September 3, 2025, Full and Open Competition After Exclusion of Sources, 16 offers | NIH NCINational Institutes of Health | Phase I SBIR Concept Award for Logic Gated Molecular Adaptor System for JMML TreatmentNAICS 541715, PSC AN12 | $499,990 |
| 75N91023C00014Definitive Contract, February 26, 2024, Full and Open Competition After Exclusion of Sources, 17 offers | NIH NCINational Institutes of Health | The Purpose of This Modification Is to Extend the Period of Performance from February 26, 2024 to August 26, 2024NAICS 541715, PSC AN12 | $0 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 5 across 2 awards